Search Result for : Pharma Trade

The Dollar Business Bureau In a bid to facilitate exports and make easier to do business, the Government on Wednesday eased the guidelines for drugs, medical devices and cosmetics exporters. Now the pharmaceutical companies will no longer have to get ‘no-objection’ certificate (NOC) from regulatory authority to export drugs and medical devices. “The pharmaceutical exporters can continue exporting without having to obtain no-objection certificates (NOC) from the regulatory authorities,” said the Central Drugs Standard Control Organisation (CDSCO) in a notice. Earlier, this facility was only available for exports to Australia, US, Japan, Canada, and European Union. Now CDSCO has extended the rule for exports to all other countries. “In partial modification of notice of even number dated December 11, 2015, removing the requirement of NOC for ...

The Dollar Business Bureau A leading Indian pharmaceuticals company Aurobindo Pharma has said that it would widen its product portfolio in the American market while planning to enter new markets in the Europe, a part of the company’s growth strategy in the coming 3-4 years. In the US market, Aurobindo Pharma plans to widen its portfolio through faster growth in OTC, injectable and higher complexity products, the company said in a presentation to investors. However, in European market, the company plans to enhance its presence in new geographies like Czech Republic and Poland, in addition to strengthening its position in the existing markets of Germany, France, Spain, Netherlands and the UK. Aurobindo Pharma is the 6th largest generic company by volume in the US, ...

The Dollar Business Bureau India’s major pharmaceuticals companies are now looking to acquire niche product portfolios in several regulated markets across the world, indicated a report on Tuesday. "Recently, selected innovators have taken a call to exit their generics business and concentrate on branded/patented businesses creating billion dollar acquisition opportunities for large Indian pharma players in the regulated markets," said the report published by ICICI Securities. The country’s largest ten pharmaceutical companies, which are incidentally cash-rich, are hungry to acquire companies with their niche product portfolios. The report pointed out that the top Indian pharma companies have plethora of funds, and they can raise capital easily from debt and equity capital markets. In September, UCB sold Kremers Urban to Lannett for $1.23 billion and India-based generics portfolios ...

The Dollar Business Bureau Indian government has come up with a proposal for the crisis-hit Venezuela for settling the dues of India’s pharmaceutical companies through the oil that it shipped to India. “The Government of India has put-forth an 'oil for export mechanism' between government of Venezuela and Government of India to settle pending payments of pharmaceutical companies,” Commerce and Industry Minister Nirmala Sitharaman said in a written response to the Rajya Sabha. The Minister said that the proposal tries to find out a mechanism to balance the payments, which are due to be done to the oil firms of Venezuela against the payments due of Indian companies. "However, the Venezuelan side has not given any response yet," she added. The pharmaceutical exporters of India ...

Sairaj Iyer | The Dollar Business Bureau   Hudu Mogtari the CEO of Ghana FDA gave a compelling and visionary presentation during the second day proceedings of Iphex at Bombay Exhibition Center, Goregaon. Mogtari arrived at the session with a contingent of policy-makers and industrialists from Ghana. There were senior officials from the Ghana health ministry, a member of the Parliament, and the executive secretary of the pharmaceutical association of Ghana, that jubilantly backed Hudu Mogtari while he delivered his presentation. Mogtari revealed that Ghana produced a mere 30% of domestic-healthcare needs, forcing them to depend on imports. In that respect Indian drugs are not only cost-effective but also of great quality. During his session he announced that to facilitate easier imports from ...

Aadhira Anandh   The 4th edition of Pharma Pro &Pack Expo 2016, an international exhibition for Pharma’s technology and trade was unveiled on 27th April in Mumbai. The event is being organized by India Pharma Machinery Manufacturers Association (IPMMA) and GPE Exports Pvt. Ltd. Hosted in association with the EEPC India and PHARMEXCIL, the expo largely concentrates on the Indian Pharma engineering and the Indian Pharmaceutical Industry. The expo provided a common platform for trade opportunities to MSME’s on both national and international levels.  Simultaneously in another part of the exhibition ground Pharma Lab Expo 2016, an international exhibition of total pharma manufacturing technologies was organized. It focused on providing the experience of new technologies to the pharma buyers and sellers in the industry.  The ...